Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Helminth neuromuscular junction ion channels are specialized protein complexes, including nicotinic acetylcholine receptors and other ligand- or voltage-gated channels, located at the neuromuscular junctions of parasitic worms. They mediate the conversion of nervous signals to muscle contraction for processes such as movement and feeding. These channels are highly conserved but often exhibit significant structural differences from their mammalian counterparts, allowing for parasite-selective drug targeting. Many frontline anthelmintic drugs act as agonists or antagonists at these channels, producing rapid paralysis and expulsion of the parasite. Resistance has emerged in several helminth populations due to mutations in key channel subunits, presenting ongoing therapeutic challenges[6].
Agonist or antagonist activity at nicotinic acetylcholine receptors, causing depolarization block (spastic or flaccid paralysis) Modulation of glutamate-gated or GABA-gated chloride channels (e.g., causing hyperpolarization and muscle relaxation)[6]
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Helminth neuromuscular junction ion channel.